Literature DB >> 19857806

The treatment of liver fibrosis induced by hepatocyte growth factor-directed, ultrasound-targeted microbubble destruction in rats.

Zhao-Xia Wang1, Zhi-Gang Wang, Hai-Tao Ran, Jian-Li Ren, Yong Zhang, Qiao Li, Ye-Feng Zhu, Meng Ao.   

Abstract

OBJECTIVE: The purpose of this study was to explore the feasibility of using ultrasound-targeted microbubble destruction to treat liver fibrosis induced by hepatocyte growth factor (HGF).
METHODS: Forty Wistar rats were divided into five groups after the models of liver fibrosis were prepared: (1) HGF, ultrasound, and microbubbles (HGF+US/MB); (2) HGF and ultrasound (HGF+US); (3) HGF and microbubbles (HGF+MB); (4) HGF (HGF); and (5) model alone (MA). All rats were killed after being transfected for 14 days. Recovery of the liver was detect by diffusion-weighted imaging (DWI) and pathological methods. Collagen I expression was detected by immunohistochemistry. Hepatocyte growth factor expression in the liver was detect by western blotting.
RESULTS: The results of DWI and pathological examination showed the recovery of liver in HGF+US/MB group were better than those of other groups. In HGF+US/MB group, collagen I expression was less, and HGF protein was the highest among all the groups.
CONCLUSIONS: Ultrasound-targeted microbubble destruction could deliver HGF into the fibrotic liver and produce an antifibrosis effect, which could provide a novel strategy for gene therapy of liver fibrosis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19857806     DOI: 10.1016/j.clinimag.2009.07.001

Source DB:  PubMed          Journal:  Clin Imaging        ISSN: 0899-7071            Impact factor:   1.605


  11 in total

Review 1.  New pharmacological treatments for improving renal outcomes in diabetes.

Authors:  Anne-Emilie Declèves; Kumar Sharma
Journal:  Nat Rev Nephrol       Date:  2010-05-04       Impact factor: 28.314

2.  Cultivating hepatocytes on printed arrays of HGF and BMP7 to characterize protective effects of these growth factors during in vitro alcohol injury.

Authors:  Caroline N Jones; Nazgul Tuleuova; Ji Youn Lee; Erlan Ramanculov; A Hari Reddi; Mark A Zern; Alexander Revzin
Journal:  Biomaterials       Date:  2010-05-21       Impact factor: 12.479

3.  Inhibition of the ubiquitin ligase activity improves the production of biologically active fusion protein HSA-HGF in Chinese hamster ovary cells.

Authors:  Dongsheng Xu; Aini Wan; Jingjing Zhang; Lin Peng; Yun Chen; Yang He; Jianfeng Yang; Jian Jin
Journal:  Bioengineered       Date:  2016-10-18       Impact factor: 3.269

4.  Hepatic stellate cell-targeted delivery of hepatocyte growth factor transgene via bile duct infusion enhances its expression at fibrotic foci to regress dimethylnitrosamine-induced liver fibrosis.

Authors:  Balakrishnan Chakrapani Narmada; Yuzhan Kang; Lakshmi Venkatraman; Qiwen Peng; Rashidah Binte Sakban; Bramasta Nugraha; Xuan Jiang; Ralph M Bunte; Peter T C So; Lisa Tucker-Kellogg; Hai-Quan Mao; Hanry Yu
Journal:  Hum Gene Ther       Date:  2013-05       Impact factor: 5.695

Review 5.  Pathogenesis of liver cirrhosis.

Authors:  Wen-Ce Zhou; Quan-Bao Zhang; Liang Qiao
Journal:  World J Gastroenterol       Date:  2014-06-21       Impact factor: 5.742

6.  Ultrasound-targeted microbubble destruction mediated herpes simplex virus-thymidine kinase gene treats hepatoma in mice.

Authors:  Shiji Zhou; Shengwei Li; Zuojin Liu; Yong Tang; Zhigang Wang; Jianping Gong; Changan Liu
Journal:  J Exp Clin Cancer Res       Date:  2010-12-23

7.  Inhibitory effects of the ultrasound-targeted microbubble destruction-mediated herpes simplex virus-thymidine kinase/ganciclovir system on ovarian cancer in mice.

Authors:  Xian-Long Zhou; Yu-Lu Shi; Xiong Li
Journal:  Exp Ther Med       Date:  2014-08-04       Impact factor: 2.447

Review 8.  Advances in ultrasound-targeted microbubble-mediated gene therapy for liver fibrosis.

Authors:  Cuiyuan Huang; Hong Zhang; Ruidan Bai
Journal:  Acta Pharm Sin B       Date:  2017-03-15       Impact factor: 11.413

Review 9.  Advances in ultrasound mediated gene therapy using microbubble contrast agents.

Authors:  Shashank R Sirsi; Mark A Borden
Journal:  Theranostics       Date:  2012-12-31       Impact factor: 11.556

10.  New Concepts on Reversibility and Targeting of Liver Fibrosis; A Review Article.

Authors:  Hedyeh Ebrahimi; Mohammadreza Naderian; Amir Ali Sohrabpour
Journal:  Middle East J Dig Dis       Date:  2018-06-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.